These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15898821)

  • 1. Urofollitropin and ovulation induction.
    van Wely M; Yding Andersen C; Bayram N; van der Veen F
    Treat Endocrinol; 2005; 4(3):155-65. PubMed ID: 15898821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective, multicenter, assessor-blind, randomized, clinical trial. European Puregon Collaborative Anovulation Study Group.
    Coelingh Bennink HJ; Fauser BC; Out HJ
    Fertil Steril; 1998 Jan; 69(1):19-25. PubMed ID: 9457926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follitropin alpha in infertility: a review.
    Goa KL; Wagstaff AJ
    BioDrugs; 1998 Mar; 9(3):235-60. PubMed ID: 18020563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 2000; 1996(2):CD000087. PubMed ID: 10796690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction.
    Zafeiriou S; Loutradis D; Michalas S
    Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):157-67. PubMed ID: 10943580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovulation induction in clomiphene-resistant anovulatory women: differential follicular response to purified urinary follicle-stimulating hormone (FSH) versus purified urinary FSH and luteinizing hormone.
    Hoffman DI; Lobo RA; Campeau JD; Tsai HM; Holmberg EA; Ono T; Frederick JJ; Platt LD; diZerega GS
    J Clin Endocrinol Metab; 1985 May; 60(5):922-7. PubMed ID: 3920235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follicle-stimulating hormone in clinical practice: an update.
    Daya S
    Treat Endocrinol; 2004; 3(3):161-71. PubMed ID: 16026112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of ovulation in polycystic ovary: human menopausal gonadotropin or human urinary follicle stimulating hormone?
    Venturoli S; Paradisi R; Fabbri R; Porcu E; Orsini LF; Flamigni C
    Int J Fertil; 1987; 32(1):66-70. PubMed ID: 2880819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic and endocrine comparison of recombinant follicle-stimulating hormone and human menopausal gonadotrophin in polycystic ovary syndrome.
    Balasch J; Fábregues F; Casamitjana R; Peñarrubia J; Vanrell JA
    Reprod Biomed Online; 2003; 6(3):296-301. PubMed ID: 12735863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum FSH levels in women with polycystic ovary syndrome during ovulation induction using down-regulation and urofollitropin.
    Fridström M; Sjöblom P; Pousette A; Hillensjö T
    Eur J Endocrinol; 1997 May; 136(5):488-92. PubMed ID: 9186269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic low-dose follicle-stimulating hormone compared with clomiphene/human menopausal gonadotropin for induction of ovulation.
    Yong EL; Ng SC; Chan CL; Kumar J; Teo LS; Ratnam SS
    Gynecol Endocrinol; 1997 Feb; 11(1):35-42. PubMed ID: 9086338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis.
    Revelli A; Poso F; Gennarelli G; Moffa F; Grassi G; Massobrio M
    Reprod Biol Endocrinol; 2006 Jul; 4():38. PubMed ID: 16848893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.
    Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R
    Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The step-down principle in gonadotrophin treatment and the role of GnRH analogues.
    Fauser BC; Donderwinkel P; Schoot DC
    Baillieres Clin Obstet Gynaecol; 1993 Jun; 7(2):309-30. PubMed ID: 8358893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of gonadotropins for the induction of ovulation in women with polycystic ovarian disease.
    Raj SG; Berger MJ; Grimes EM; Taymor ML
    Fertil Steril; 1977 Dec; 28(12):1280-4. PubMed ID: 590534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome.
    Homburg R; Levy T; Ben-Rafael Z
    Fertil Steril; 1995 Apr; 63(4):729-33. PubMed ID: 7890055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain.
    Burgués S;
    Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP).
    Lenton E; Soltan A; Hewitt J; Thomson A; Davies W; Ashraf N; Sharma V; Jenner L; Ledger W; McVeigh E
    Hum Reprod; 2000 May; 15(5):1021-7. PubMed ID: 10783345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study.
    Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S
    J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.